J&J to exit spinoff Kenvue with latest stake sale
Tylenol maker Kenvue said that Johnson & Johnson (JNJ.N) will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.